Know Labs (NYSEAMERICAN:KNW) Now Covered by Analysts at Benchmark

Equities researchers at Benchmark started coverage on shares of Know Labs (NYSEAMERICAN:KNW) in a report released on Monday, Benzinga reports. The firm set a “speculative buy” rating and a $1.00 price target on the stock. Benchmark’s target price would indicate a potential upside of 56.30% from the company’s current price.

Know Labs Stock Up 0.8 %

NYSEAMERICAN KNW opened at $0.64 on Monday. The company has a market cap of $52.05 million, a PE ratio of -1.73 and a beta of 1.63. Know Labs has a 52 week low of $0.23 and a 52 week high of $1.48.

Know Labs (NYSEAMERICAN:KNW) last announced its quarterly earnings results on Wednesday, February 14th. The company reported ($0.04) earnings per share (EPS) for the quarter. On average, equities analysts anticipate that Know Labs will post -0.08 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in KNW. Vanguard Group Inc. lifted its holdings in Know Labs by 3.3% during the 4th quarter. Vanguard Group Inc. now owns 497,773 shares of the company’s stock worth $253,000 after purchasing an additional 15,790 shares in the last quarter. Citadel Advisors LLC purchased a new stake in Know Labs during the 4th quarter worth about $77,000. Northern Trust Corp lifted its holdings in Know Labs by 27.7% during the 4th quarter. Northern Trust Corp now owns 100,710 shares of the company’s stock worth $51,000 after purchasing an additional 21,823 shares in the last quarter. Callan Capital LLC lifted its holdings in Know Labs by 117.6% during the 4th quarter. Callan Capital LLC now owns 370,000 shares of the company’s stock worth $188,000 after purchasing an additional 200,000 shares in the last quarter. Finally, Walleye Capital LLC purchased a new stake in Know Labs during the 3rd quarter worth about $180,000. Hedge funds and other institutional investors own 23.96% of the company’s stock.

Know Labs Company Profile

Know Labs, Inc, together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.